Shares of drug firm Wockhardt are in action even as the benchmark indices declined in early trade on Tuesday, December 2, 2025, amid uncertainty over repo rate cuts. The counter opened in green at Rs ...
NEW DELHI: (Dec 1) Drug firm Wockhardt on Monday said the US health regulator has accepted the new drug application (NDA) status for its novel, first-in-class antibiotic Zaynich. The NDA was filed on ...
UPSC NDA-1 results 2025: The Union Public Service Commission (UPSC) has announced the results for the Central Armed Police Forces (CAPF) Assistant Commandants (ACs) and the National Defence Academy ...